Natixis Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-24,505
| Closed | -$4.5M | – | 1376 |
|
2021
Q2 | $4.5M | Buy |
24,505
+675
| +3% | +$124K | 0.02% | 672 |
|
2021
Q1 | $3.64M | Sell |
23,830
-22,112
| -48% | -$3.38M | 0.02% | 696 |
|
2020
Q4 | $7.18M | Sell |
45,942
-22,857
| -33% | -$3.57M | 0.04% | 442 |
|
2020
Q3 | $7.87M | Buy |
68,799
+3,806
| +6% | +$436K | 0.05% | 385 |
|
2020
Q2 | $7.3M | Buy |
64,993
+24,562
| +61% | +$2.76M | 0.05% | 396 |
|
2020
Q1 | $3.63M | Buy |
40,431
+8,894
| +28% | +$799K | 0.03% | 561 |
|
2019
Q4 | $3.41M | Buy |
31,537
+10,262
| +48% | +$1.11M | 0.02% | 671 |
|
2019
Q3 | $2.08M | Sell |
21,275
-5,521
| -21% | -$541K | 0.02% | 765 |
|
2019
Q2 | $3.51M | Buy |
26,796
+2,522
| +10% | +$330K | 0.03% | 581 |
|
2019
Q1 | $3.28M | Buy |
24,274
+3,623
| +18% | +$490K | 0.03% | 585 |
|
2018
Q4 | $2.01M | Sell |
20,651
-3,539
| -15% | -$345K | 0.02% | 710 |
|
2018
Q3 | $3.36M | Buy |
24,190
+41
| +0.2% | +$5.7K | 0.03% | 609 |
|
2018
Q2 | $3M | Buy |
24,149
+578
| +2% | +$71.8K | 0.03% | 629 |
|
2018
Q1 | $2.63M | Buy |
23,571
+4,618
| +24% | +$515K | 0.03% | 678 |
|
2017
Q4 | $2.27M | Sell |
18,953
-308
| -2% | -$36.8K | 0.02% | 681 |
|
2017
Q3 | $2.7M | Buy |
19,261
+2,308
| +14% | +$324K | 0.03% | 636 |
|
2017
Q2 | $2.06M | Buy |
16,953
+3,335
| +24% | +$406K | 0.02% | 690 |
|
2017
Q1 | $1.65M | Buy |
13,618
+808
| +6% | +$98K | 0.02% | 747 |
|
2016
Q4 | $1.57M | Buy |
12,810
+2,760
| +27% | +$338K | 0.02% | 730 |
|
2016
Q3 | $1.23M | Sell |
10,050
-2,145
| -18% | -$263K | 0.02% | 759 |
|
2016
Q2 | $1.42M | Buy |
12,195
+1,194
| +11% | +$139K | 0.02% | 712 |
|
2016
Q1 | $1.53M | Sell |
11,001
-1,713
| -13% | -$239K | 0.02% | 688 |
|
2015
Q4 | $2.43M | Buy |
12,714
+1,827
| +17% | +$348K | 0.04% | 547 |
|
2015
Q3 | $1.7M | Sell |
10,887
-50
| -0.5% | -$7.82K | 0.03% | 639 |
|
2015
Q2 | $1.98M | Sell |
10,937
-16,970
| -61% | -$3.07M | 0.03% | 638 |
|
2015
Q1 | $4.84M | Buy |
27,907
+2,520
| +10% | +$437K | 0.08% | 359 |
|
2014
Q4 | $4.7M | Buy |
25,387
+2,392
| +10% | +$443K | 0.09% | 352 |
|
2014
Q3 | $3.81M | Buy |
22,995
+2,108
| +10% | +$350K | 0.08% | 395 |
|
2014
Q2 | $3.26M | Buy |
20,887
+6,382
| +44% | +$997K | 0.05% | 561 |
|
2014
Q1 | $2.21M | Buy |
14,505
+9,309
| +179% | +$1.42M | 0.03% | 606 |
|
2013
Q4 | $690K | Buy |
5,196
+3,274
| +170% | +$435K | 0.01% | 824 |
|
2013
Q3 | $223K | Buy |
+1,922
| New | +$223K | ﹤0.01% | 1051 |
|